We are live on ! Find out more
VCYT icon

Veracyte

214 hedge funds and large institutions have $3.47B invested in Veracyte in 2021 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 77 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $2.91B → $3.47B (+$560M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 29

0% less funds holding

Funds holding: 215214 (-1)

6% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 77

2.23% less ownership

Funds ownership: 108.23%106% (-2.2%)

29% less call options, than puts

Call options by funds: $617K | Put options by funds: $870K

Holders
214
Holders Change
-1
Holders Change %
-0.47%
% of All Funds
3.74%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
29
Increased
72
Reduced
77
Closed
29
Calls
$617K
Puts
$870K
Net Calls
-$253K
Net Calls Change
+$283K

VCYT Hedge Fund Activity: Q3 2021 in Review

214 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2021, worth a combined $3.47B — up 19% from $2.91B a quarter earlier.

Fund positioning in VCYT was balanced in Q3 2021: 29 funds opened new positions, 29 closed out, 72 added to existing stakes and 77 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $101M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $70.9M.

  • 214 institutional investors held Veracyte (VCYT) as of Q3 2021, down from 215 in Q2 2021.
  • Funds reported $3.47B of Veracyte stock for Q3 2021, up 19% quarter-over-quarter.
  • 29 funds opened new Veracyte positions in Q3 2021 and 29 closed out, a net change of 0 holders.
  • The largest Veracyte buyer in Q3 2021 was Wellington Management Group, an estimated $101M added.
  • The largest Veracyte seller in Q3 2021 was Gilder Gagnon Howe & Co, an estimated $70.9M sold.

Based on aggregated 13F filings for Q3 2021.